Canature Health Technology Co., Ltd. (300272.SZ)
CNY 6.74
(-0.3%)
CNY 6.74
(-0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.67 Billion | 1.66 Billion | 1.51 Billion | 1.18 Billion | 1.05 Billion | 901.02 Million |
| Cost of Revenue | 1.05 Billion | 1.09 Billion | 1 Billion | 665.34 Million | 587.69 Million | 550.25 Million |
| Gross Profit | 615.87 Million | 563.82 Million | 505.38 Million | 515.77 Million | 464.83 Million | 350.76 Million |
| Operating Expenses | 454.06 Million | 420.52 Million | 355.48 Million | 352.15 Million | 341.1 Million | 289.85 Million |
| Selling, General and Administrative Expenses | 386.21 Million | 184.28 Million | 159.59 Million | 201.62 Million | 199.93 Million | 165.42 Million |
| Research and Development Expenses | 67.41 Million | 66.81 Million | 54.58 Million | 35.86 Million | 18.78 Million | 34.77 Million |
| Other Expenses | 432.29 Thousand | 8.63 Million | -9.12 Million | 18.95 Million | 18.09 Million | 16.39 Million |
| Cost and Expenses | 1.5 Billion | 1.51 Billion | 1.36 Billion | 1.01 Billion | 928.79 Million | 840.1 Million |
| Operating Income | 161.8 Million | 113 Million | 152.18 Million | 46.59 Million | 158.72 Million | 360.91 Million |
| Interest Expense | 32.58 Million | 16.84 Million | 16.28 Million | 15.05 Million | 13.87 Million | 8.59 Million |
| Income Tax Expense | 5.32 Million | 14.84 Million | 28.39 Million | 15.77 Million | 56.83 Million | 28.01 Million |
| Earnings before Tax | 158.8 Million | 114.27 Million | 145.49 Million | 66.3 Million | 177.28 Million | 377.31 Million |
| Net Income | 132.44 Million | 92.56 Million | 104.85 Million | 26.41 Million | 100.51 Million | 348.01 Million |
| Earnings Per Share Basic | 0.24 | 0.17 | 0.18 | 0.05 | 0.17 | 0.61 |
| Earnings Per Share Diluted | 0.23 | 0.17 | 0.18 | 0.05 | 0.17 | 0.61 |
| Weighted Average Shares Outstanding | 551.86 Million | 561.7 Million | 567.17 Million | 528.35 Million | 574.93 Million | 570.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 575.85 Million | 561.7 Million | 567.17 Million | 528.35 Million | 574.93 Million | 570.51 Million |
| Gross Margin | 0.37 | 0.34 | 0.33 | 0.44 | 0.44 | 0.39 |
| EBIT Margin | 0.17 | 0.14 | 0.14 | 0.17 | 0.20 | 0.46 |
| Profit Margin | 0.08 | 0.06 | 0.07 | 0.02 | 0.10 | 0.39 |
| EBITDA | 291.01 Million | 206.87 Million | 242.57 Million | 118.67 Million | 232.08 Million | 440.83 Million |
| Earnings Before Tax Margin | 0.10 | 0.07 | 0.10 | 0.04 | 0.15 | 0.40 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 424.7 Million | 446.51 Million | 378.06 Million | 430.13 Million | 1.67 Billion | 445.85 Million |
| Cost of Revenue | 255.67 Million | 274.62 Million | 228.73 Million | 289.24 Million | 1.04 Billion | 263.58 Million |
| Gross Profit | 169.02 Million | 171.89 Million | 149.32 Million | 140.88 Million | 627.41 Million | 182.27 Million |
| Operating Expenses | 115.62 Million | 111.12 Million | 110.65 Million | 112.44 Million | 456.81 Million | 117.3 Million |
| Selling, General and Administrative Expenses | 239.18 Million | 95.42 Million | 95.05 Million | -81.38 Million | - | 187.53 Million |
| Research and Development Expenses | 14.84 Million | 13.73 Million | 15.61 Million | 20.7 Million | - | 15.67 Million |
| Other Expenses | -138.41 Million | -1.97 Million | 8790.00 | 24.83 Million | 24.11 Million | -341.92 Thousand |
| Cost and Expenses | 371.29 Million | 385.75 Million | 339.39 Million | 401.69 Million | 1.5 Billion | 380.88 Million |
| Operating Income | 39.33 Million | 60.76 Million | 38.66 Million | 9.53 Million | 161.8 Million | 80.03 Million |
| Interest Expense | 7.89 Million | 8.78 Million | 8.23 Million | 4.93 Million | 28.43 Million | 8.91 Million |
| Income Tax Expense | 2.51 Million | 15.02 Million | 5.1 Million | 1.74 Million | 5.32 Million | -7.45 Million |
| Earnings before Tax | 38.96 Million | 66.81 Million | 40.17 Million | 7.24 Million | 158.8 Million | 79.69 Million |
| Net Income | 27.13 Million | 34.74 Million | 22.29 Million | 3.12 Million | 132.44 Million | 75.53 Million |
| Earnings Per Share Basic | 0.05 | 0.06 | 0.04 | 0.01 | - | 0.13 |
| Earnings Per Share Diluted | 0.05 | 0.06 | 0.04 | 0.01 | - | 0.13 |
| Weighted Average Shares Outstanding | 565.06 Million | 565.06 Million | 570.11 Million | 604.81 Million | 551.86 Million | 561.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 565.06 Million | 565.06 Million | 589.71 Million | 604.7 Million | 575.85 Million | 561.7 Million |
| Gross Margin | 0.40 | 0.38 | 0.39 | 0.33 | 0.38 | 0.41 |
| EBIT Margin | 0.11 | 0.18 | 0.11 | 0.10 | - | 0.14 |
| Profit Margin | 0.06 | 0.08 | 0.06 | 0.01 | 0.08 | 0.17 |
| EBITDA | 46.85 Million | 80.53 Million | 42.28 Million | 44.87 Million | - | 60.97 Million |
| Earnings Before Tax Margin | 0.09 | 0.14 | 0.10 | 0.02 | 0.10 | 0.18 |
MAV
603053
TRBK
PSA-PG
SHECY
EJFI